LeMaitre Vascular Return on Investment 2010-2024 | LMAT

Current and historical return on investment (ROI) values for LeMaitre Vascular (LMAT) over the last 10 years.
LeMaitre Vascular ROI - Return on Investment Historical Data
Date TTM Net Income LT Investments & Debt Return on Investment
2024-06-30 $0.05B inf%
2024-03-31 $0.04B inf%
2023-12-31 $0.04B inf%
2023-09-30 $0.03B inf%
2023-06-30 $0.03B inf%
2023-03-31 $0.03B inf%
2022-12-31 $0.03B inf%
2022-09-30 $0.03B inf%
2022-06-30 $0.03B inf%
2022-03-31 $0.04B 70.24%
2021-12-31 $0.04B 35.04%
2021-09-30 $0.04B 24.56%
2021-06-30 $0.04B $0.21B 19.12%
2021-03-31 $0.03B $0.21B 16.48%
2020-12-31 $0.03B $0.21B 19.50%
2020-09-30 $0.02B $0.20B 24.81%
2020-06-30 $0.02B $0.19B 42.11%
2020-03-31 $0.02B inf%
2019-12-31 $0.02B inf%
2019-09-30 $0.02B inf%
2019-06-30 $0.02B inf%
2019-03-31 $0.03B inf%
2018-12-31 $0.03B inf%
2018-09-30 $0.03B inf%
2018-06-30 $0.03B inf%
2018-03-31 $0.02B inf%
2017-12-31 $0.02B inf%
2017-09-30 $0.02B inf%
2017-06-30 $0.02B inf%
2017-03-31 $0.02B inf%
2016-12-31 $0.02B inf%
2016-09-30 $0.02B inf%
2016-06-30 $0.01B inf%
2016-03-31 $0.01B inf%
2015-12-31 $0.01B inf%
2015-09-30 $0.01B inf%
2015-06-30 $0.01B inf%
2015-03-31 $0.01B inf%
2014-12-31 $0.01B inf%
2014-09-30 $0.01B inf%
2014-06-30 $0.00B inf%
2014-03-31 $0.00B inf%
2013-12-31 $0.00B inf%
2013-09-30 $0.00B inf%
2013-06-30 $0.00B inf%
2013-03-31 $0.00B inf%
2012-12-31 $0.00B inf%
2012-09-30 $0.00B inf%
2012-06-30 $0.01B inf%
2012-03-31 $0.01B inf%
2011-12-31 $0.00B inf%
2011-09-30 $0.00B inf%
2011-06-30 $0.00B 15.69%
2011-03-31 $0.00B 12.00%
2010-12-31 $0.00B 10.74%
2010-09-30 $0.01B $0.05B 12.18%
2010-06-30 $0.01B $0.05B 10.31%
2010-03-31 $0.00B $0.05B 8.38%
2009-12-31 $0.00B $0.05B 2.15%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $2.061B $0.193B
LeMaitre Vascular, Inc. is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects the people worldwide. LeMaitre develops, manufactures, and markets disposable and implantable vascular devices to address the needs of vascular surgeons and interventionalists. LeMaitre's diversified product portfolio consists of twelve well-known brand name products used in arteries and veins outside of the heart and are supported by a growing, specialized and highly trained organization of vascular sales professionals. LeMaitre Vascular offers a wide range of innovative products to vascular surgeons and interventionalists for improving procedure efficacy and minimizing patient recovery time.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $195.617B 25.27
Stryker (SYK) United States $137.290B 32.08
Boston Scientific (BSX) United States $122.743B 37.38
Medtronic (MDT) Ireland $114.552B 17.05
EssilorLuxottica (ESLOY) France $108.842B 0.00
Haleon (HLN) United Kingdom $48.651B 35.57
Lonza Group Ag (LZAGY) Switzerland $46.030B 0.00
ResMed (RMD) United States $35.117B 30.92
Koninklijke Philips (PHG) Netherlands $30.774B 23.39
Terumo (TRUMY) Japan $28.517B 40.27
Zimmer Biomet Holdings (ZBH) United States $22.039B 13.87
Baxter (BAX) United States $19.851B 13.46
Insulet (PODD) United States $16.269B 68.45
Smith & Nephew SNATS (SNN) United Kingdom $13.605B 0.00
Bio-Rad Laboratories (BIO) United States $9.247B 30.63
Demant (WILYY) Denmark $8.667B 0.00
BellRing Brands (BRBR) United States $7.898B 33.39
Lantheus Holdings (LNTH) United States $7.454B 17.89
ICU Medical (ICUI) United States $4.261B 40.67
Haemonetics (HAE) United States $4.084B 20.20
TG Therapeutics (TGTX) United States $3.689B 39.07
Neogen (NEOG) United States $3.599B 37.75
Prestige Consumer Healthcare (PBH) United States $3.534B 17.61
GN Store Nord (GNNDY) Denmark $3.509B 21.14
Perrigo (PRGO) Ireland $3.499B 11.06
Envista Holdings (NVST) United States $3.398B 18.13
QuidelOrtho (QDEL) United States $3.063B 19.30
Agios Pharmaceuticals (AGIO) United States $2.595B 0.00
Green Thumb Industries (GTBIF) United States $2.226B 37.36
Maravai LifeSciences Holdings (MRVI) United States $2.124B 0.00
Warby Parker (WRBY) United States $1.614B 0.00
AdaptHealth (AHCO) United States $1.497B 10.81
InMode (INMD) Israel $1.464B 9.32
AtriCure (ATRC) United States $1.372B 0.00
Owens & Minor (OMI) United States $1.247B 9.63
Verano Holdings (VRNOF) United States $1.184B 0.00
BioLife Solutions (BLFS) United States $1.123B 0.00
Evolus (EOLS) United States $1.006B 0.00
PetIQ (PETQ) United States $0.919B 23.30
Phibro Animal Health (PAHC) United States $0.894B 18.55
National Vision Holdings (EYE) United States $0.867B 27.55
Cresco Labs (CRLBF) United States $0.805B 0.00
Surmodics (SRDX) United States $0.549B 116.64
Quanterix (QTRX) United States $0.489B 0.00
VAREX IMAGING (VREX) United States $0.488B 14.72
Jin Medical (ZJYL) China $0.439B 0.00
ZimVie (ZIMV) United States $0.435B 40.41
Valneva SE (VALN) France $0.432B 0.00
Canopy Growth (CGC) Canada $0.402B 0.00
TerrAscend (TSNDF) Canada $0.389B 0.00
Cerus (CERS) United States $0.324B 0.00
Capricor Therapeutics (CAPR) United States $0.324B 0.00
OraSure Technologies (OSUR) United States $0.320B 8.25
Aurora Cannabis (ACB) Canada $0.319B 0.00
Biote (BTMD) United States $0.307B 14.18
Viemed Healthcare (VMD) United States $0.283B 30.38
Sanara MedTech (SMTI) United States $0.264B 0.00
Zynex (ZYXI) United States $0.257B 45.00
Utah Medical Products (UTMD) United States $0.232B 15.41
Omeros (OMER) United States $0.227B 0.00
MacroGenics (MGNX) United States $0.200B 0.00
Ayr Wellness (AYRWF) United States $0.194B 0.00
Organigram Holdings (OGI) Canada $0.191B 0.00
High Tide (HITI) Canada $0.163B 67.33
FitLife Brands (FTLF) United States $0.153B 20.64
Brainsway (BWAY) Israel $0.135B 161.40
TriSalus Life Sciences (TLSI) United States $0.130B 0.00
Quipt Home Medical (QIPT) United States $0.121B 0.00
Rockwell Medical (RMTI) United States $0.114B 0.00
Veru (VERU) United States $0.113B 0.00
Fonar (FONR) United States $0.111B 11.44
Jushi Holdings (JUSHF) United States $0.104B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.101B 24.80
InterCure (INCR) Israel $0.087B 14.62
Zevia PBC (ZVIA) United States $0.083B 0.00
Cytosorbents (CTSO) United States $0.082B 0.00
Modular Medical (MODD) United States $0.074B 0.00
Cellectar Biosciences (CLRB) United States $0.073B 0.00
Safety Shot (SHOT) United States $0.071B 0.00
MariMed (MRMD) United States $0.065B 0.00
Exagen (XGN) United States $0.055B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.051B 3.35
Apyx Medical (APYX) United States $0.042B 0.00
Allurion Technologies (ALUR) United States $0.040B 0.00
ImmuCell (ICCC) United States $0.028B 0.00
Meihua Medical Technologies (MHUA) China $0.026B 0.00
Nephros (NEPH) United States $0.018B 0.00
Flora Growth (FLGC) United States $0.018B 0.00
Innovative Eyewear (LUCY) United States $0.014B 0.00
GlucoTrack (GCTK) United States $0.013B 0.00
Trinity Biotech (TRIB) Ireland $0.008B 0.00
NeuroMetrix (NURO) United States $0.008B 0.00
GUARDION HEALTH (GHSI) United States $0.007B 0.00
Agape ATP (ATPC) $0.007B 0.00
Leafly Holdings (LFLY) United States $0.006B 0.00
IM Cannabis (IMCC) Canada $0.005B 0.00
Sharps Technology (STSS) United States $0.005B 0.00
Senestech (SNES) United States $0.001B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.001B 0.00
Akanda (AKAN) United Kingdom $0.000B 0.00
United-Guardian (UG) United States $0.000B 21.30
SNDL (SNDL) Canada $0.000B 0.00